CIK 0001754068 · Non-accelerated filer<br>Smaller reporting company
Kalaris Therapeutics, Inc.
Sign in to watch- Ticker
- KLRS
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 831971007
- Phone
- 650-249-2727
- Business address
- 400 CONNELL DRIVE, SUITE 5500, BERKELEY HEIGHTS, NJ, 07922
- Former names
- Allovir, Inc., ViraCyte, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-03-18 | Feinsod Matthew Chief Medical Officer | Grant or award · Stock Option (right to buy) | +28,224 | 28,224 | ||
| 2025-03-18 | Oxtoby Andrew See Remarks | Grant or award · Stock Option (right to buy) | +476,611 | 476,611 | ||
| 2025-03-18 | AKKARAJU SRINIVAS Director | Grant or award | +11,444,503 | 11,444,503 | ||
| 2025-03-18 | ADAMIS ANTHONY P Director | Grant or award · Stock Option (right to buy) | +19,484 | 19,484 | ||
| 2025-03-18 | ADAMIS ANTHONY P Director | Grant or award · Stock Option (right to buy) | +12,989 | 12,989 | ||
| 2025-02-21 | Sinha Vikas See Remarks | Sale | −303 | $10.08 | $3K | 49,129 |
| 2025-02-21 | Hagen Brett R Chief Accounting Officer | Sale | −96 | $10.08 | $967 | 2,832 |
| 2025-02-21 | Miller Edward General Counsel | Sale | −106 | $10.08 | $1K | 6,517 |
| 2025-01-23 | Miller Edward General Counsel | Sale | −47 | $9.45 | $444 | 6,628 |
| 2025-01-23 | Miller Edward General Counsel | Sale | −5 | $9.94 | $50 | 6,623 |
| 2025-01-23 | Hagen Brett R Chief Accounting Officer | Sale | −32 | $9.45 | $303 | 2,932 |
| 2025-01-23 | Hagen Brett R Chief Accounting Officer | Sale | −4 | $9.94 | $40 | 2,928 |
| 2025-01-23 | Sinha Vikas See Remarks | Sale | −116 | $9.45 | $1K | 49,445 |
| 2025-01-23 | Sinha Vikas See Remarks | Sale | −13 | $9.94 | $129 | 49,432 |
| 2025-01-10 | Miller Edward General Counsel | Sale | −409 | $0.44 | $180 | 153,541 |
| 2025-01-10 | Hagen Brett R Chief Accounting Officer | Sale | −332 | $0.44 | $146 | 68,174 |
| 2025-01-10 | Sinha Vikas See Remarks | Sale | −979 | $0.44 | $431 | 1,139,915 |
| 2024-12-11 | Miller Edward General Counsel | Gift | −57,549 | 153,950 | ||
| 2024-12-11 | Miller Edward General Counsel | Gift | +57,549 | 346,348 | ||
| 2024-11-19 | Hagen Brett R Chief Accounting Officer | Sale | −554 | $0.55 | $304 | 68,506 |
Page 3 of 7 · 122 trades